PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

27/05/2009

VAT status

Active

Bankruptcy proceedings

No proceedings

PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Lowest

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

07/05/2009

Share capital

179,000.00 PLN

Primary activity

Agents involved in the sale of machinery, industrial equipment, ships and aircraft (46.14.Z - PKD 2007)

Representatives

Representatives rights

DO SKŁADANIA OŚWIADCZEŃ WOLI, REPREZENTOWANIA SPÓŁKI I ZACIĄGANIA ZOBOWIĄZAŃ WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU LUB CZŁONKA ZARZĄDU I PROKURENTA (REPREZENTACJA ŁĄCZNA).

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-461,209

Net Profit (zł)

-461,209

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
3,010,755
414,729
414,729
0.16
2.65
13.77
481,630
291,373
0
0

2023
3,217,169
380,515
377,570
0.19
2.20
11.74
625,637
523,000
0
0

2024
1,801,245
-461,209
-461,209
0.04
1.21
-25.61
72,895
345,124
0
-

2024
1,801,245
-461,209
-461,209
0.04
1.21
-25.61
72,895
345,124
0
-

Turnover (zł)

2024

Turnover (zł)

1,801,245 zł-44 % *

Profit before tax (zł)

-461,209 zł-221 % *

Net Profit (zł)

-461,209 zł-222 % *

Working capital requirement (%)

0.04 -78.95 % *

Liquidity ratio

1.21 -45.00 % *

Net profitability (%)

-25.61 %-318.14 % *

Equity (zł)

72,895 zł-88 % *

Current liabilities (zł)

345,124 zł-34 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
10/07/2025	OD 01.01.2024 DO 31.12.2024
27/06/2024	OD 01.01.2023 DO 31.12.2023
06/07/2023	OD 01.01.2022 DO 31.12.2022
29/08/2022	OD 01.01.2021 DO 31.12.2021
14/10/2021	OD 01.01.2020 DO 31.12.2020